M. Breda

发表

Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC-MS/MS.

P. Tassone, M. D. Di Martino, S. Franzoni, 2018, Journal of pharmaceutical and biomedical analysis.

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin

H. Rosing, J. Beijnen, J. Lieverst, 2002, British Journal of Cancer.

Development and validation of an inductively coupled plasma mass spectrometry method with optimized microwave-assisted sample digestion for the determination of platinum at ultratrace levels in plasma and ultrafiltrate plasma.

M. Musci, A. Mangia, M. Maffini, 2008, Journal of pharmaceutical and biomedical analysis.

Ion-suppression effects in liquid chromatography-tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis.

D. Fraier, C. James, P. Larger, 2005, Journal of pharmaceutical and biomedical analysis.

A review of analytical methods for the determination of 5-fluorouracil in biological matrices

M. Breda, S. Barattè, 2010, Analytical and bioanalytical chemistry.

Fast turnaround bioanalysis in discovery and early clinical development

K. Munesada, C. James, J. Long, 2002 .

Special problems associated with the bioanalysis of anti-cancer drugs

K. Munesada, C. James, J. Long, 2002 .

Validation of an LC-MS/MS method for the quantification IOA-289 in human plasma and its application in a first-in-human clinical trial.

J. Franchi, M. Deken, A. Vezzelli, 2022, Journal of pharmaceutical and biomedical analysis.

Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues.

C. James, M. Breda, R. Pisano, 2005, Journal of pharmaceutical and biomedical analysis.

Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry.

C. James, G. Basileo, M. Breda, 2003, Journal of pharmaceutical and biomedical analysis.

Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.

I. Poggesi, P. Dostert, M. Benedetti, 2000, Pharmacological research.

Determination of exemestane, a new aromatase inhibitor, in plasma by high-performance liquid chromatography with ultraviolet detection.

M. Benedetti, E. Pianezzola, M. Breda, 1993, Journal of chromatography.

Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of enmetazobactam and cefepime in human plasma.

A. Vezzelli, A. Greco, M. Breda, 2019, Journal of pharmaceutical and biomedical analysis.

P. Sacerdote, P. Meroni, A. Panerai, 1991, Peptides.

Analysis of Drugs and Metabolites in Tissues and Other Solid Matrices

C. James, E. Frigerio, M. Breda, 2004 .

Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma

M. Rocchetti, P. Nygren, N. Sarapa, 2003, Cancer Chemotherapy and Pharmacology.

Effect of rifabutin on ethambutol pharmacokinetics in healthy volunteers.

M. Rocchetti, I. Poggesi, M. Bani, 1999, Pharmacological research.

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Jennifer Zimmer, Xinping Fang, 2012, Bioanalysis.

Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Xinping Fang, Zhongping John Lin, 2012, Bioanalysis.

Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration.

E. Zecca, A. Panerai, V. Ventafridda, 1991, International journal of clinical pharmacology research.

Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762).

D. Bissett, P. Wilson, P. Vasey, 1995, Cancer research.

Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS.

P. Tassone, P. Tagliaferri, M. Arbitrio, 2020, Journal of pharmaceutical and biomedical analysis.

Development and validation of a highly sensitive gradient chiral separation of pramipexole in human plasma by LC-MS/MS.

S. Dworetzky, J. Belardi, L. Solazzo, 2017, Bioanalysis.

Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects

F. Fiorentini, L. Calzà, B. Imbimbo, 2013, Alzheimer disease and associated disorders.

A STUDY OF THE EFFECTS OF RIFABUTIN ON ISONIAZID PHARMACOKINETICS AND METABOLISM IN HEALTHY VOLUNTEERS

C. Efthymiopoulos, D. Sassella, M. Benedetti, 1992, Drug Metabolism and Drug Interactions.

Determination of ethambutol in human plasma and urine by high-performance liquid chromatography with fluorescence detection.

M. Strolin Benedetti, P. Marrari, E. Pianezzola, 1996, Journal of chromatography. A.

Enantioselective determination of FCE 28833, a new potential antiischemic agent, in gerbil plasma using column switching HPLC with UV detection.

P. Dostert, G. Basileo, M. Breda, 1997, Chirality.

Bioanalytical method validation: a risk-based approach?

C. James, C A James, M Breda, 2004, Journal of pharmaceutical and biomedical analysis.

Conference report: the 3rd Global CRO Council for Bioanalysis at the International Reid Bioanalytical Forum.

Fabio Garofolo, Rachel Green, Jaap Wieling, 2011, Bioanalysis.

Determination of 3'-deamino-3'-[2(S)-methoxy-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detection.

M. Benedetti, E. Pianezzola, M. Breda, 1992, Journal of chromatography.

Blood Microsampling in cynomolgus monkey and evaluation of plasma PK parameters in comparison to conventional sampling.

M. Pecoraro, M. Breda, A. Tagliavini, 2023, Journal of pharmacological and toxicological methods.